Search research articles
Contact Us
Filters
Showing results (291-300 of 484) with videos related to
Page
of 49
Sort By:
European Heart Journal
|
May 27, 2010
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
Hiddo J Lambers Heerspink, Toshiharu Ninomiya, Vlado Perkovic, et al.
JACC. Heart Failure
|
November 3, 2019
Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes
JingWei Li, Mark Woodward, Vlado Perkovic, et al.
International Journal of Cardiology
|
September 26, 2020
An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials
Jie Yu, Zien Zhou, Kenneth W Mahaffey, et al.
Nutrition & Dietetics : the Journal of the Dietitians Association of Australia
|
July 10, 2024
Modifying the Health Star Rating nutrient profiling algorithm to account for ultra-processing
Eden M Barrett, Simone Pettigrew, Bruce Neal, et al.
European Journal of Nutrition
|
July 26, 2023
Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia
Kristy A Bolton, Joseph Alvin Santos, Emalie Rosewarne, et al.
Journal of the American Society of Nephrology : JASN
|
July 23, 2020
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program
Megumi Oshima, Bruce Neal, Tadashi Toyama, et al.
Diabetes, Obesity & Metabolism
|
January 26, 2017
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial
Bruce Neal, Vlado Perkovic, David R Matthews, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
April 9, 2014
The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion
Mary-Anne Land, Jacqui Webster, Anthea Christoforou, et al.
Journal of the American Society of Nephrology : JASN
|
September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
BMC Public Health
|
July 22, 2025
Stakeholder perspectives on scaling up potassium-enriched salt to reduce cardiovascular disease in Australia: a qualitative study
Juliette Crowther, Annet C Hoek, Kathy Trieu, et al.
Page
of 49
Search research articles
Search
Showing results (291-300 of 484) with videos related to
Sort By:
Page
of 49
European Heart Journal
|
May 27, 2010
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
Hiddo J Lambers Heerspink, Toshiharu Ninomiya, Vlado Perkovic, et al.
JACC. Heart Failure
|
November 3, 2019
Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes
JingWei Li, Mark Woodward, Vlado Perkovic, et al.
International Journal of Cardiology
|
September 26, 2020
An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials
Jie Yu, Zien Zhou, Kenneth W Mahaffey, et al.
Nutrition & Dietetics : the Journal of the Dietitians Association of Australia
|
July 10, 2024
Modifying the Health Star Rating nutrient profiling algorithm to account for ultra-processing
Eden M Barrett, Simone Pettigrew, Bruce Neal, et al.
European Journal of Nutrition
|
July 26, 2023
Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia
Kristy A Bolton, Joseph Alvin Santos, Emalie Rosewarne, et al.
Journal of the American Society of Nephrology : JASN
|
July 23, 2020
Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program
Megumi Oshima, Bruce Neal, Tadashi Toyama, et al.
Diabetes, Obesity & Metabolism
|
January 26, 2017
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial
Bruce Neal, Vlado Perkovic, David R Matthews, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
April 9, 2014
The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion
Mary-Anne Land, Jacqui Webster, Anthea Christoforou, et al.
Journal of the American Society of Nephrology : JASN
|
September 19, 2019
Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
BMC Public Health
|
July 22, 2025
Stakeholder perspectives on scaling up potassium-enriched salt to reduce cardiovascular disease in Australia: a qualitative study
Juliette Crowther, Annet C Hoek, Kathy Trieu, et al.
Page
of 49